FINWIRES · TerminalLIVE
FINWIRES

HKG:2410

3 stories mentioning HKG:2410Updated just now

Every FINWIRES story that references HKG:2410, newest first.

Asia

TYK Medicines' Chairman Boosts Stake; Shares Down 8%

TYK Medicines (HKG:2410) said Chairman and Chief Executive Officer Wu Yusheng has recently purchased company shares on the open market and may make further purchases depending on market conditions.The total increase in his shareholding is currently expected not to exceed HK$2 million, according to a Hong Kong bourse filing.Wu will fund the purchases with his own funds and has undertaken to voluntarily lock up the shares acquired over the next month for six months from their respective purchase dates.Shares of the firm were down nearly 10% in Wednesday morning trade.

HKG:2410
Asia

TYK Medicines' Lung Cancer Drug Candidate Secures Marketing Nod in China; Shares Slide 6%

TYK Medicines' (HKG:2410) asandeutertinib mesylate tablets obtained conditional approval for marketing from China's National Medical Products Administration, according to a Thursday bourse filing.Shares of the pharmaceutical company were down nearly 6% in Friday afternoon trading.The approval is for the indication of the first-line treatment for adult patients with locally advanced or metastatic non-small cell lung cancer.

HKG:2410
Asia

TYK Medicines Challenges TY-9591 Cooperation Agreement in Court; Shares Fall 4%

TYK Medicines (HKG:2410) has filed legal proceedings seeking a court ruling that purported cooperation and distribution agreements with Sichuan Huiyu Pharmaceutical relating to TY-9591 were never formed and are invalid.Huiyu has also filed a separate case involving the same agreements with the People's Court of Neijiang City's Shizhong District, according to a Hong Kong bourse filing on Wednesday. Both cases have been accepted by the courts but have not yet been heard.TYK said the litigation has not materially affected its business, operations or cash flow.Shares of TYK fell nearly 4% in recent trade.

HKG:2410

Track with the FINWIRES app suite

FolioX
FolioX
Track HKG:2410 in your portfolio
WheelAI
WheelAI
Analyze HKG:2410 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on HKG:2410